OCA at 08:18, 11 October 2023

OCA — Wed, 11 Oct 2023 08:18:13 GMT

←Older revision		Revision as of 08:18, 11 October 2023
Line 1:		Line 1:

-	====	+	==Structure of NCI09 fab in complex with SIV V2 peptide==
-	<StructureSection load='6vry' size='340' side='right'caption='[[6vry]]' scene=''>	+	<StructureSection load='6vry' size='340' side='right'caption='[[6vry]], [[Resolution\|resolution]] 1.40Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id= OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://proteopedia.org/fgij/fg.htm?mol= FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[6vry]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Macaca_mulatta Macaca mulatta] and [https://en.wikipedia.org/wiki/Simian_immunodeficiency_virus Simian immunodeficiency virus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6VRY OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6VRY FirstGlance]. <br>
-	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://proteopedia.org/fgij/fg.htm?mol=6vry FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6vry OCA], [~~http~~://pdbe.org/6vry PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=6vry RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/6vry PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=6vry ProSAT]</span></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.4Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=FUC:ALPHA-L-FUCOSE'>FUC</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6vry FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6vry OCA], [https://pdbe.org/6vry PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6vry RCSB], [https://www.ebi.ac.uk/pdbsum/6vry PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6vry ProSAT]</span></td></tr>
	</table>		</table>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/ENV_SIVM2 ENV_SIVM2] The surface protein gp120 (SU) attaches the virus to the host lymphoid cell by binding to the primary receptor CD4. This interaction induces a structural rearrangement creating a high affinity binding site for a chemokine coreceptor like CCR5. This peculiar 2 stage receptor-interaction strategy allows gp120 to maintain the highly conserved coreceptor-binding site in a cryptic conformation, protected from neutralizing antibodies. These changes are transmitted to the transmembrane protein gp41 and are thought to activate its fusogenic potential by unmasking its fusion peptide (By similarity). Surface protein gp120 (SU) may target the virus to gut-associated lymphoid tissue (GALT) by binding host ITGA4/ITGB7 (alpha-4/beta-7 integrins), a complex that mediates T-cell migration to the GALT. Interaction between gp120 and ITGA4/ITGB7 would allow the virus to enter GALT early in the infection, infecting and killing most of GALT's resting CD4+ T-cells. This T-cell depletion is believed to be the major insult to the host immune system leading to AIDS (By similarity). The surface protein gp120 is a ligand for CD209/DC-SIGN and CLEC4M/DC-SIGNR, which are respectively found on dendritic cells (DCs), and on endothelial cells of liver sinusoids and lymph node sinuses. These interactions allow capture of viral particles at mucosal surfaces by these cells and subsequent transmission to permissive cells. DCs are professional antigen presenting cells, critical for host immunity by inducing specific immune responses against a broad variety of pathogens. They act as sentinels in various tissues where they take up antigen, process it, and present it to T-cells following migration to lymphoid organs. SIV subverts the migration properties of dendritic cells to gain access to CD4+ T-cells in lymph nodes. Virus transmission to permissive T-cells occurs either in trans (without DCs infection, through viral capture and transmission), or in cis (following DCs productive infection, through the usual CD4-gp120 interaction), thereby inducing a robust infection. In trans infection, bound virions remain infectious over days and it is proposed that they are not degraded, but protected in non-lysosomal acidic organelles within the DCs close to the cell membrane thus contributing to the viral infectious potential during DCs' migration from the periphery to the lymphoid tissues. On arrival at lymphoid tissues, intact virions recycle back to DCs' cell surface allowing virus transmission to CD4+ T-cells. Virion capture also seems to lead to MHC-II-restricted viral antigen presentation, and probably to the activation of SIV-specific CD4+ cells (By similarity). The transmembrane protein gp41 (TM) acts as a class I viral fusion protein. Under the current model, the protein has at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of viral and target intracellular membranes, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes. Complete fusion occurs in host cell endosomes. The virus undergoes clathrin-dependent internalization long before endosomal fusion, thus minimizing the surface exposure of conserved viral epitopes during fusion and reducing the efficacy of inhibitors targeting these epitopes. Membranes fusion leads to delivery of the nucleocapsid into the cytoplasm (By similarity). The envelope glycoprotein gp160 precursor down-modulates cell surface CD4 antigen by interacting with it in the endoplasmic reticulum and blocking its transport to the cell surface. The gp120-gp41 heterodimer allows rapid transcytosis of the virus through CD4 negative cells such as simple epithelial monolayers of the intestinal, rectal and endocervical epithelial barriers. Both gp120 and gp41 specifically recognize glycosphingolipids galactosyl-ceramide (GalCer) or 3' sulfo-galactosyl-ceramide (GalS) present in the lipid rafts structures of epithelial cells. Binding to these alternative receptors allows the rapid transcytosis of the virus through the epithelial cells. This transcytotic vesicle-mediated transport of virions from the apical side to the basolateral side of the epithelial cells does not involve infection of the cells themselves (By similarity).
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: ~~Z-disk~~]]	+	[[Category: Macaca mulatta]]
		+	[[Category: Simian immunodeficiency virus]]
		+	[[Category: Ahmadi M]]
		+	[[Category: Gorman J]]
		+	[[Category: Kwong PD]]

OCA at 06:44, 30 December 2020

OCA — Wed, 30 Dec 2020 06:44:12 GMT

←Older revision		Revision as of 06:44, 30 December 2020
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 6vry ~~is ON HOLD until Paper Publication~~	+	====
-		+	<StructureSection load='6vry' size='340' side='right'caption='[[6vry]]' scene=''>
-	~~Authors~~: ~~Gorman, J~~.~~, Ahmadi, M~~.~~, Kwong, P~~.D.	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id= OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol= FirstGlance]. <br>
-	~~Description~~: ~~Structure of NCI09 fab in complex with SIV V2 peptide~~	+	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6vry FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6vry OCA], [http://pdbe.org/6vry PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6vry RCSB], [http://www.ebi.ac.uk/pdbsum/6vry PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6vry ProSAT]</span></td></tr>
-	[[~~Category~~: ~~Unreleased Structures~~]]	+	</table>
-	[[~~Category~~: ~~Gorman~~, J]]	+	__TOC__
-	[[Category: ~~Kwong, P.D~~]]	+	</StructureSection>
-	[[Category: ~~Ahmadi, M~~]]	+	[[Category: Large Structures]]
		+	[[Category: Z-disk]]

OCA at 05:36, 4 March 2020

OCA — Wed, 04 Mar 2020 05:36:10 GMT

←Older revision		Revision as of 05:36, 4 March 2020
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 6vry is ON HOLD	+	The entry 6vry is ON HOLD until Paper Publication

	Authors: Gorman, J., Ahmadi, M., Kwong, P.D.		Authors: Gorman, J., Ahmadi, M., Kwong, P.D.
Line 7:		Line 7:
	Description: Structure of NCI09 fab in complex with SIV V2 peptide		Description: Structure of NCI09 fab in complex with SIV V2 peptide
	[[Category: Unreleased Structures]]		[[Category: Unreleased Structures]]
-	[[Category: Kwong, P.D]]
	[[Category: Gorman, J]]		[[Category: Gorman, J]]
		+	[[Category: Kwong, P.D]]
	[[Category: Ahmadi, M]]		[[Category: Ahmadi, M]]

OCA: Protected "6vry" [edit=sysop:move=sysop]

OCA — Wed, 19 Feb 2020 05:19:38 GMT

Protected "6vry" [edit=sysop:move=sysop]

←Older revision

Revision as of 05:19, 19 February 2020

OCA: New page: '''Unreleased structure''' The entry 6vry is ON HOLD Authors: Gorman, J., Ahmadi, M., Kwong, P.D. Description: Structure of NCI09 fab in complex with SIV V2 peptide [[Category: Unrelea...

OCA — Wed, 19 Feb 2020 05:19:37 GMT

New page: '''Unreleased structure''' The entry 6vry is ON HOLD Authors: Gorman, J., Ahmadi, M., Kwong, P.D. Description: Structure of NCI09 fab in complex with SIV V2 peptide [[Category: Unrelea...

New page

'''Unreleased structure'''

The entry 6vry is ON HOLD

Authors: Gorman, J., Ahmadi, M., Kwong, P.D.

Description: Structure of NCI09 fab in complex with SIV V2 peptide
[[Category: Unreleased Structures]]
[[Category: Kwong, P.D]]
[[Category: Gorman, J]]
[[Category: Ahmadi, M]]

6vry - Revision history

OCA at 08:18, 11 October 2023

OCA at 06:44, 30 December 2020

OCA at 05:36, 4 March 2020

OCA: Protected "6vry" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 6vry is ON HOLD Authors: Gorman, J., Ahmadi, M., Kwong, P.D. Description: Structure of NCI09 fab in complex with SIV V2 peptide [[Category: Unrelea...